An Evaluation of the Use of Corticosteroids for the Management of Immune-Mediated Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have gained prominence for the treatment of a variety of malignancies. However, they are associated with the development of immune-mediated adverse events (IMAEs). Appropriate management of IMAEs and subsequent rechallenging of patients with ICI therapy remains an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsui, Adrian, Edmondson, Lindsay, Julius, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Research & Scholarship
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017796/
https://www.ncbi.nlm.nih.gov/pubmed/34109046
http://dx.doi.org/10.6004/jadpro.2021.12.2.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017796/
https://www.ncbi.nlm.nih.gov/pubmed/34109046
http://dx.doi.org/10.6004/jadpro.2021.12.2.2

Ejemplares similares